Soluble form of CTLA‐4 is a good predictor for tumor recurrence after radiofrequency ablation in hepatocellular carcinoma patients

BACKGROUND: A soluble form of cytotoxic‐T‐lymphocyte‐antigen‐4 (sCTLA‐4) is a prognostic biomarker for several cancers but remains unclear in HCC patients. The aim of study is to evaluate the predictive role of serum sCTLA‐4 levels for tumor recurrence of chronic hepatis C (CHC)‐HCC patients receivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Wei, Jeng, Wen‐Juei, Chen, Wei‐Ting, Lin, Chen‐Chun, Lin, Chun‐Yen, Lin, Shi‐Ming, Sheen, I‐Shyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582685/
https://www.ncbi.nlm.nih.gov/pubmed/35435327
http://dx.doi.org/10.1002/cam4.4760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582685/
https://www.ncbi.nlm.nih.gov/pubmed/35435327
http://dx.doi.org/10.1002/cam4.4760

Ejemplares similares